oHCM Regional Summit

A new era in treating obstructive hypertrophic cardiomyopathy (oHCM)

3-4 October 2025
Grand Hotel Union Eurostars
Ljubljana, Slovenia

Registration

Meet Our Speakers

Dr. Egle Tamulenaite-Stuoke, MD
Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Lithuania
Biography

Egle Tamulenaite-Stuoke is a cardiologist in Lithuania, specializing in biomarkers and imaging for hypertrophic cardiomyopathy (HCM). Focusing on HCM, analyzing the prognostic value of ventricular and atrial morphology, function, and mechanics, as well as genotype and biological markers, in patients with HCM.

Key Contributions to oHCM
  • Biomarker Research: Pioneered use of NT-proBNP and hs-troponins for oHCM risk assessment in Lithuania.
  • Imaging Expertise: Advocates non-invasive ultrasound- based imaging techniques, computed tomography (CT).
  • Regional Advocacy: Promotes standardized diagnostic protocols in Lithuania and region.
Contact and Professional Links
Assoc. Prof. Michelle Michels, MD, PhD
Erasmus Medical Center, Rotterdam, Netherlands
Prof. Aleš Linhart, MD, DrS., PhD, FESC, FCMA
Charles University, Prague, Czech Republic
Prof. Zlatko Fras, MD, PhD, FESC, FACC, FRCP (Lond)
University Medical Centre Ljubljana and Medical Faculty, University of Ljubljana, Slovenia
Academician Prof. Davor Miličić, MD, PhD, FESC, FHFA, FACC
University of Zagreb, Croatian Academy of Science and Arts, Croatia
Assist. Janez Toplišek, MD, PhD
University Medical Centre Ljubljana, Slovenia
Assist. Prof. Ivo Planinc, MD, PhD, FHFA
University Hospital Centre Zagreb, Croatia
Prof. Snezhanka Tisheva, MD, DMSc
Medical University of Sofia, Bulgaria
Assoc. Prof. Ainars Rudzitis, MD PhD
Pauls Stradins Clinical University Hospital, Riga, Latvia
Marcela Dankova, MD, PhD.
National Cardiovascular Institute, Slovakia
Dr. Kairit Palm, MD
East Central Tallinn Hospital, Estonia